Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

EPT Disclosure

12 Jun 2006 11:34

Deutsche Bank AG London12 June 2006 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Deutsche Bank AG London Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the Ordinarydealings being disclosed relate (Note 1) Date of dealing 09/06/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 5,508 £13.105 £13.0659 Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 9,016 £13.085 £13.0659 (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)e.g. CFD CFD Short 4,508 £13.066 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. Date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. NONE Date of disclosure 12/06/2006 Contact name Kelly-Jade Ledwich Telephone number 020 7545 7804 Name of offeree/offeror with which connected AstraZeneca PlcNature of connection (Note 6) Adviser to the offeror Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Mar 20227:00 amRNSScheme of arrangement -Sanction Hearing & Timeline
28th Feb 20227:00 amRNSScheme of arrangement - Voting deadline 1 March
24th Feb 20227:00 amRNSScheme of arrangement - US Bankruptcy Court
18th Feb 20223:04 pmRNSScheme of arrangement - Notices of Scheme Meetings
17th Feb 20227:00 amRNSScheme of arrangement - Convening Order
14th Feb 20225:31 pmRNSScheme of arrangement - Directions Hearing
11th Feb 20227:00 amRNSScheme of arrangement - Amendment of Undertakings
7th Feb 20227:00 amRNSNet Asset Value(s)
4th Feb 20227:00 amRNSScheme of arrangement - improved terms
23rd Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20212:00 pmRNSScheme of arrangement - Update
10th Dec 20217:00 amRNSScheme of arrangement - Update
18th Nov 20211:00 pmRNSNet Asset Value(s)
12th Nov 20217:00 amRNSResults of early extended deadline & update
9th Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20215:09 pmRNSScheme of arrangement chapter 15 recognition order
1st Nov 20216:01 pmRNSScheme of arrangement Convening Hearing
28th Oct 202112:09 pmRNSPractice Direction Letter
26th Oct 20213:04 pmRNSCorrection - Scheme of arrangement improved terms
26th Oct 20217:00 amRNSScheme of arrangement and Improved Terms
15th Oct 20217:00 amRNSNet Asset Value(s)
7th Oct 20213:40 pmRNSCommencement of US Chapter 15 Proceedings
1st Oct 20212:59 pmRNSUpdate re government enquiries at Markel CATCo
27th Sep 20217:05 amRNSHalf-year Report
27th Sep 20217:00 amRNSScheme of arrangement
17th Sep 20217:00 amRNSNet Asset Value(s)
9th Sep 20219:00 amRNSHolding(s) in Company
31st Aug 20217:00 amRNSNet Asset Value(s)
21st Jul 20217:00 amRNSNet Asset Value(s)
25th Jun 20217:00 amRNSNet Asset Value(s)
10th Jun 20214:31 pmRNSHolding(s) in Company
4th Jun 20213:27 pmRNSHolding(s) in Company
24th May 20217:00 amRNSNet Asset Value(s)
20th May 20217:00 amRNSHolding(s) in Company
19th May 202111:31 amRNSHolding(s) in Company
13th May 20215:43 pmRNSHolding(s) in Company
12th May 20217:00 amRNSTransaction in Own Shares - Compulsory Redemption
30th Apr 20217:00 amRNSCompulsory Acqn of Shares
28th Apr 20219:02 amRNSHolding(s) in Company
22nd Apr 20211:45 pmRNSResults of AGM
22nd Apr 20217:00 amRNSNet Asset Value(s)
15th Apr 20217:00 amRNSAdditional Side Pocket Releases
24th Mar 20217:00 amRNSNet Asset Value(s)
18th Mar 202111:38 amRNSHolding(s) in Company
16th Mar 20213:56 pmRNSAnnual Financial Report for year ended 31 Dec 2020
9th Mar 202112:39 pmRNSHolding(s) in Company
8th Mar 20211:52 pmRNSHolding(s) in Company
5th Mar 202112:45 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSNet Asset Value(s)
11th Feb 20211:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.